Abstract: New series of N-(arylidene)hydrazinoacetyl sulfonamides 4a 1-6 , 4b 1-6 and N-(4-aryl-3-chloro-2-oxoazetidin-1-yl)aminoacetyl sulfonamides 5a 1-6 , 5b 1-6 were synthesized. The structures of the new derivatives was confirmed using spectral methods (FT-IR, synthesized compounds was also investigated according to ferric reducing power, total antioxidant activity and DPPH radical scavenging assays. All tested compounds showed excellent antioxidant activity in comparison with sulfadiazine and sulfisoxazole which were used as parent sulfonamides. Moreover, some of them showed an antioxidant activity comparable with that of ascorbic acid. In general, the compounds designed based on a sulfadiazine skeleton (compounds 4a 1-6 , 5a 1-6 ) are more active than those obtained from sulfisoxazole (compounds 4b 1-6 , 5b 1-6 ) , and the N-(arylidene)hydrazinoacetyl sulfonamide derivatives 4a 1-6 , 4b 1-6 are more active than their azetidionone analogues 5a 1-6 , 5b 1-6 .
Introduction
The 2-azetidinone skeleton, otherwise known as the β-lactam ring, has been recognized as a useful building block in the synthesis of biologically important compounds. Azetindin-2-one derivatives display interesting biological activities such as antifungal, antimicrobial [1] [2] [3] [4] , antitubercular [5, 6] , analgesic, anti-inflammatory [7, 8] , chymase inhibitory [9] , antitumoral [10] [11] [12] , antiviral, antidiabetic and cholesterol absorption inhibitory properties [13] . The activity of famous antibiotic classes such as the penicillins, cephalosporins, carumonam, aztreonam, thienamicine, nocardicins and carbapenems is attributed to the presence of an 2-azetidinone ring [2] . Unfortunately, the most widely used of them exert selective pressure on bacteria and permit the proliferation of resistant organisms. Several synthetic and semi-synthetic β-lactam antibiotics were developed due to the growing resistance of bacteria towards the classical β-lactam antibiotics and the need for drugs with a more specific antibacterial activity [1] . The biological activity of sulfonamides is also well documented. They have be found to be useful in a variety of applications, including antibacterial, antifungal, antitumor agents, diuretics, carbonic anhydrase inhibitors, hypoglycemic agents, thyroid inhibitors, anticonvulsants and protease inhibitors [14, 15] . Among antibacterial sulfonamides, sulfadiazine and its silver and cerium salts have an important place. They are widely used as topical agents for the management of burns where they prevent infections and promote rapid healing with minimal scarring [15] .
Wounds are physical injuries that result in an opening of the skin. Proper healing of wounds is essential for the restoration of disrupted anatomical continuity and disturbed functional status of the skin [16] . Normal healing of wounds is a dynamic process following three phases: inflammation, granulation (tissue formation) and re-epithelization (tissue remodeling), which overlap in time [17] . It was proven that reactive oxygen species (ROS) and bacterial infections are deleterious to the wound healing process due to their harmful effects on cells and tissues [18] . ROS are produced in high amounts at wound sites as a defense mechanism against invading bacteria. At the same time, the process of wound healing may be hampered by the presence of free radicals, which can damage the cells surrounding the wound, or by microbial infection [19] and recent data has proved the beneficial effects of antioxidants in the wound healing process [20] [21] [22] . In the present study, we are reporting the design, synthesis and biological evaluation of some new 2-azetidinone derivatives of sulfadiazine and sulfisoxazole with potential use in wound healing processes.
Results and Discussion

Chemistry
Azetidinone derivatives 5a [1] [2] [3] [4] [5] [6] , 5b [1] [2] [3] [4] [5] [6] were prepared using the method summarized in Scheme 1. First, sulfadiazine (4-amino-N-pyrimidin-2-yl-benzensulfonamide, 1a) and sulfisoxazole [4- amino-N-(3,4-dimethyl-1,2-oxazol-5-yl)benzensulfonamide, 1b] were reacted with chloroacetyl chloride whereby the corresponding chloracetyl derivatives 2a-b were obtained. Compounds 2a-b on amination with hydrazine hydrate afforded hydrazinoacetyl sulfonamide derivatives 3a-b [23] . The condensation reaction of compounds 3a-b with various aromatic aldehydes yielded N-(arylidene)hydrazinoacetyl sulfonamide derivatives 4a [1] [2] [3] [4] [5] [6] , 4b [1] [2] [3] [4] [5] [6] . Finally, the compounds 4a 1-6 , 4b 1-6 upon reaction with chloracetyl chloride in the presence of triethylamine afforded N-(4-aryl-3-chloro-2-oxoazetidin-1-yl)aminoacetyl sulfonamides 5a [1] [2] [3] [4] [5] [6] , 5b 1-6 . Scheme 1. Synthesis of azetidinone derivatives (5a 1-6 , 5b [1] [2] [3] [4] [5] [6] ). The structure of the compounds was assigned on the basis of spectral (IR,   1 H-NMR, 13 C-NMR) data. The IR spectra of compounds 4a 1-6 (sulfadiazine series) showed absorption bands for the -CH 2 -NHgroup in the range of 2830-2853 cm range. In the spectra of the sulfisoxazole derivatives 4b 1-6 the characteristic absorption bands were observed in the region of 2842-2870 cm H-NMR spectra of the N-(arylidene)hydrazinoacetyl sulfonamides 4a 1-6 , 4b 1-6 the -CH 2 -NH methylene protons resonated as a doublet in the 3.56-3.79 ppm region, while the proton of the azomethine group (N=CH) appeared as a singlet in the 8.06-8.22 ppm region. In the IR spectra of the azetidinone derivatives 5a [1] [2] [3] [4] [5] [6] , 5b 1-6 the carbonyl group of the β-lactam ring appeared as a characteristic absorption band in the range of 1739-1745 cm H-NMR signals characteristic of the azomethine group disappeared from the spectra of the azetidinone derivatives, which confirms that the cyclization reaction with chloracetyl chloride took place. The 1 H-NMR spectra of 5a 1-6 (sulfadiazine series) and 5b 1-6 (sulfisoxazole series) showed two doublets, which are characteristic for N-CH and CH-Cl that appear in the range of 5.32-5.45 and 5.02-5.23 ppm, respectively. In 13 C-NMR spectra of the azetidinone derivatives, the characteristic signals for a β-lactam ring (CH-NH, CH-Cl, CO cyclic) appeared in the range of 67.8-76.1, 61.04-64.3 and 160.3-162.8 ppm (5a 1-6 series) and 75.9-79.1, 64.2-67.0 and 160.3-168.2 ppm (5b 1-6 series) respectively. The spectral data lend strong support to the proposed structures of all the synthesized compounds.
Biological Evaluation
Antibacterial Activity
The antibacterial activities of the title compounds were evaluated using the broth micro-dilution method [24] and the results are listed Tables 1 and 2 . 3 >512 >512 >512 >512 >512 >512 >512 >512 >512 4a 4 >512 >512 >512 >512 >512 >512 >512 >512 128 4a 5 >512 >512 >512 >512 >512 >512 >512 >512 >512 4a 6 >512 >512 >512 >512 >512 >512 >512 >512 >512 5a 1 >512 >512 >512 >512 >512 >512 >512 >512 >512 5a 2 >512 >512 >512 >512 >512 >512 >512 >512 >512 5a 3 >512 >512 >512 >512 >512 >512 >512 >512 >512 5a 4 >512 >512 >512 >512 >512 >512 >512 >512 >512 5a 5 >512 >512 >512 >512 >512 >512 >512 >512 >512 5a 6 >512 >512 >512 >512 >512 >512 >512 >512 >512 S >1000 >1000 >1000 >1000 >1000 >1000 >1000 >1000 800 A 35. The minimum inhibitory concentrations (MICs) of almost all compounds were more than 512 μg/mL. The N-(arylidene)hydrazinoacetyl derivative of sulfadiazine (compound 4a 2 ) was the most active compound, as it was active on Staphyloccoccus epidermidis ATCC 12228 (128 μg/mL), Enterococcus faecalis ATCC 25912 (256 μg/mL) and Pseudomonas aeruginosa CIP 82118 (128 μg/mL). The compounds 4a 1 (256 μg/mL), 4a 4 (128 μg/mL) and 4b 5 (256 μg/mL) were active against Pseudomonas aeruginosa. All tested compounds are more active than sulfanilamide, but less active than ampicillin used as positive controls.
Antioxidant Activity
Ferric Reducing Power
The measurement of reducing power defines an important aspect of the antioxidant activity of the compounds. In this assay, the presence of a reducing agent in the sample results in reducing of the ferric/ferricyanide complex to its ferrous (Fe 2+ ) form. The amount of Fe 2+ is then quantitatively monitored by measuring the intensity of Perl's Prussian blue colour complex at 695 nm [25] . The results expressed as EC 50 values (mg/mL) are presented in Tables 3 and 4 . The small value of the EC 50 indicates a higher ferric reducing power. 3 0.0856 ± 0.0051 5a 3 0.1745 ± 0.0125 4a 4 0.0790 ± 0.0026 5a 4 0.1798 ± 0.0018 4a 5 0.0510 ± 0.0036 5a 5 0.0945 ± 0.0085 4a 6 0.0503 ± 0.0025 5a 6 0.2277 ± 0.0037 1a 2.6140 ± 0.0301 AA 0.0075 ± 0.0002
Data are mean ± SD (n = 3, p  0.05).
As it can be seen both N-(arylidene)hydrazinoacetyl and azetidinone derivatives are more active than their sulfonamide parents, sulfadiazine (1a) and sulfizoxazole (1b). In the N-(arylidene) hydrazinoacetyl series of sulfadiazine (compounds 4a 1-6 ) it was observed that the most active compounds were those which resulted from reaction of condensation with 4-hydroxybenzaldehyde (compound 4a 5 ) and 4-nitrobenzaldehyde (compound 4a 6 ). The values of EC 50 for these compounds were 0.0510 ± 0.0036 (compound 4a 5 ) and 0.0503 ± 0.0025 (compound 4a 6 ), which means that they are about 50 times more active than sulfadiazine (EC 50 = 2.6140 ± 0.0301). Concerning the azetidinone series the most active compound was 5a 5 , which is the analogue of 4a 5 in the azetidinone series. This compound is approximately 28 time more active (EC 50 = 0.0945 ± 0.0085) then sulfadiazine (EC 50 = 2.6140 ± 0.0301) ( Table 3 ). The ferric reducing power of the compounds resulting through modulation of sulfisoxazole is lower than that of the the analogues of the sulfadiazine series. In reference to sulfisoxazole (1b), all tested compounds 4b 1-6 , 5b 1-6 are more active. The most active compounds were 4b 5 [N-(arylidene)hydrazinoacetyl series] and 5b 5 (azetidinone series), which have in their structure the 4-hydroxyphenyl radical. These compounds are 46 times (4b 5 , EC 50 = 0.0210 ± 0.0065) and 10 times (5b 5 , EC 50 = 0.0935 ± 0.0098) more active, respectively, than sulfisoxazole (1b, EC 50 = 0.9640 ± 0.0443) ( Table 4) . Table 4 . Ferric reducing power (EC 50 mg/mL) of the sulfisoxazole derivatives 4b 1-6 , 5b 1-6 .
Sample
EC 50 mg/mL Sample EC 50 mg/mL 4b 1 0.0756 ± 0.0055 5b 1 0.1450 ± 0.0003 4b 2 0.2043 ± 0.0055 5b 2 0.1164 ± 0.0025 4b 3 0.0610 ± 0.0036 5b 3 0.1915 ± 0.0216 4b 4 0.0612 ± 0.0040 5b 4 0.3182 ± 0.0411 4b 5 0.0210 ± 0.0065 5b 5 0.0935 ± 0.0098 4b 6 0.1173 ± 0.0066 5b 6 0.1106 ± 0.0149 1b 0.9640 ± 0.0443 AA 0.0075 ± 0.0002
The chemical modulation of the parent sulfonamides improve their ferric reducing power and all tested compounds are more active than sulfadiazine and sulfisoxazole, respectively, but they are less active than ascorbic acid (AA) at the same concentration.
Total Antioxidant Activity
The total antioxidant activity was determined using phophomolybdenum blue complex with a maximum absorption at 695 nm [26] . The data presented in Tables 5 and 6 show that the tested compounds are more active than sulfadiazine and sulfisoxazole, respectively, and moreover, the sulfadiazine derivatives are more active than sulfisoxazole compounds. Table 5 . Total antioxidant activity (EC 50 mg/mL) of the sulfadiazine derivatives 4a 1-6 , 5a 1-6 .
Sample
EC 50 mg/mL Sample EC 50 mg/mL 4a 1 0.0180 ± 0.0044 5a 1 0.0398 ± 0.0022 4a 2 0.0280 ± 0.0067 5a 2 0.0498 ± 0.0015 4a 3 0.0110 ± 0.0007 5a 3 0.0330 ± 0.0098 4a 4 0.0360 ± 0.0089 5a 4 0.0507 ± 0.0037 4a 5 0.0440 ± 0.0050 5a 5 0.0563 ± 0.0009 4a 6 0.0220 ± 0.0072 5a 6 0.0341 ± 0.0055 1a 6.6483 ± 0.0180 AA 0.0067 ± 0.0003
Data are mean ± SD (n = 3, p  0.05). Table 6 . Total antioxidant activity (EC 50 mg/mL) of the sulfisoxazole derivatives 4b 1-6 , 5b 1-6 .
Sample EC50 mg/mL Sample EC50 mg/mL 4b 1 0.0481 ± 0.0042 5b 1 0.0433 ± 0.0009 4b 2 0.0612 ± 0.0078 5b 2 0.0756 ± 0.0033 4b 3 0.0330 ± 0.0009 5b 3 0.0574 ± 0.0025 4b 4 0.0332 ± 0.0047 5b 4 0.0385 ± 0.0078 4b 5 0.0551 ± 0.0086 5b 5 0.0718 ± 0.0008 4b 6 0.0794 ± 0.0091 5b 6 0.0825 ± 0.0045 1b 21.658 ± 0.0224 AA 0.0067 ± 0.0003
The most favorable influence seems to be the presence of halogen on the phenyl ring, especially the presence of chlorine in the sulfadiazine series (compounds 4a 3 , 5a 3 ) and the presence of chlorine and bromine in the sulfisoxazole series (compounds 4b 3-4 , 5b 3-4 ). The compound 4a 3 (EC 50 = 0.0110 ± 0.0007) is about 600 times more active than sulfadiazine (1a) (EC 50 = 6.6483 ± 0.0180) and its antioxidant activity is comparable with the activity of ascorbic acid (AA) (EC 50 = 0.0067 ± 0.0003). Although its azetidinone analogue 5a 3 has a lower activity, it remains significant in reference with sulfadiazine (Table 5 ). In the sulfisoxazole series the compounds 4b 3 (EC 50 = 0.0330 ± 0.0009) and 4b 4 (EC 50 = 0.0332 ± 0.0047) are approximately 650 time more active than sulfisoxazole (1b) (EC 50 = 21.658 ± 0.0224). Their azetidinone analogues are 380 times (5b 3 , EC 50 = 0.0574 ± 0.0025) and 560 times (5b 4 , EC 50 = 0.0385 ± 0.0078) more active than sulfisoxazole.
DPPH Radical Scavenging Assay
DPPH is a well-know radical which demonstrates a strong absorption band centered at about 517 nm, and it becomes colorless or pale yellow when it is neutralized. DPPH radical is scavenged by antioxidants through the donation of proton forming the reduced DPPH, and it is commonly used to evaluate the radical scavenging capacity of antioxidants [27] . The scavenging activities of the N-(arylidene)hydrazinoacetyl sulfonamides 4a 1-6 , 4b [1] [2] [3] [4] [5] [6] and N-(4-aryl-3-chloro-2-oxoazetidin-1-yl)aminoacetyl sulfonamides 5a [1] [2] [3] [4] [5] [6] , 5b [1] [2] [3] [4] [5] [6] , are presented in Tables 7 and 8 . All tested compounds are more active than their parent (sulfadiazine and sulfisoxazole) sulfonamides and some of them have a scavenging ability comparable with the scavenging ability of ascorbic acid. Table 7 . DPPH radical scavenging ability of sulfadiazine derivatives 4a 1-6 , 5a 1-6 .
Sample Scavenging ability (%) Sample Scavenging ability (%) 4a 1 87.73 ± 0.69 5a 1 67.18 ± 0.14 4a 2 92.22 ± 0.89 5a 2 78.25 ± 0.49 4a 3 73.09 ± 0.50 5a 3 80.94 ± 0.74 4a 4 85.66 ± 0.89 5a 4 71.52 ± 0.48 4a 5 93.17 ± 0.64 5a 5 61.28 ± 0.13 4a 6 77.28 ± 0.83 5a 6 71.61 ± 0.33 1a 11.15 ± 0.24 AA 97.08 ± 0.52 Table 8 . DPPH radical scavenging ability of sulfisoxazole derivatives 4b 1-6 , 5b 1-6 .
Sample Scavenging ability (%) Sample Scavenging ability (%) 4b 1 48.17 ± 0.63 5b 1 64.28 ± 0.49 4b 2 6.43 ± 0.41 5b 2 44.03 ± 0.13 4b 3 67.39 ± 0.52 5b 3 44.01 ± 0.86 4b 4 42.95 ± 0.23 5b 4 35.52 ± 0.48 4b 5 61.20 ± 0.68 5b 5 61.28 ± 0.13 4b 6 82.65 ± 0.18 5b 6 33.81 ± 0.09 1b 36.59 ± 0.08 AA 97.08 ± 0.52
The compounds obtained starting from sulfadiazine (compounds 4a 1-6 , 5a 1-6 , Table 7 ) are more active than sulfisoxazole derivatives 4b 1-6 , 5b [1] [2] [3] [4] [5] [6] (Table 8 ). In reference with sulfadiazine (1a), its N-(arylidene)hydrazinoacetyl derivatives 4a 1-6 are 6.5-8.4 times more active. Under similar conditions the azetidinone derivatives 5a 1-6 are slightly less active, being 5.5-7.3 more active than sulfadiazine. The most active compound is 4a 5 
; its scavenging ability (93.17 ± 0.64) being 8.4 time higher than sulfadiazine (11.15 ± 0.24) and comparable with ascorbic acid (97.08 ± 0.52).
Experimental
General Procedures
Melting points were measured using a Buchi Melting Point B-540 apparatus and are uncorrected. The FT-IR spectra were recorded on an ABB Bomen MB3000 spectrometer, over a 500-4000 cm Sulfonamides 4a 1-6 ; 4b 1-6 To a solution of hydrazinoacetyl sulfonamide derivatives (10 mmol) in ethanol 50% (200 mL), glacial acetic acid (0.5 mL) and the appropriate aldehyde (10 mmol) were added. The mixture was heated under reflux for 8 h, and then it was cooled at room temperature. The solid was filtered off, dried and recrystallized from isopropyl alcohol. Sulfonamides 5a 1-6 ; 5b [1] [2] [3] [4] [5] [6] To a solution of N-(arylidene)hydrazinoacetyl sulfonamides 4a 1-6 ; 4b 1-6 (2 mmol) in anhydrous 1,4-dioxane (50 mL), chloracetyl chloride (3 mmol) and triethylamine (2 mmol) were added dropwise at 0-5 °C. The mixture of reaction was stirred at room temperature for 3 h and the solid (triethylamine hydrochloride) was removed. The solution was heated under reflux for 5 h and then the solvent was evaporated under reduced pressure. The solid product was washed with water (20 mL), filtered off, dried and recrystallized from absolute ethanol. The progress of the reaction was monitored by silica gel coated TLC plates. 11 (m, 1H, HN-N [24] . Briefly, stock solutions were prepared by solving the substances mentioned above (200 mg) in dimethyl sulfoxide (DMSO, 19.5 mL). Using these solutions, series of two-fold dilutions were subsequently obtained. In a 9 cm diameter Petri dish, one milliliter of each dilution was mixed thoroughly with Mueller-Hinton agar (19 mL), sterilized by autoclaving and cooled to 50 °C. After this, the concentrations of the substances inside the medium were 512, 256, 128, 64, 32, 16, 8, 4, 2, and 1 μg/mL respectively. A blank plate (control of growth) was also prepared by mixing DMSO (1 mL) with molten agar (19 mL). From each bacterial strain, a 0.5 McFarland suspension was prepared in 0.85% saline solution and after that, the inoculum was standardized in order to assure 10 4 colony-forming units (CFU) per spot (5 μL). All inoculated plates were incubated for 18 h at 36 °C. The MIC was interpreted as the lowest concentration of the substance that completely inhibits the growth of bacteria in the spot area. Each determination was performed in triplicate in order to accurately confirm the MIC values.
Synthetic Procedures
Preparation of N-(arylidene)hydrazinoacetyl
Preparation of N-(4-aryl-3-chloro-2-oxoazetidin-1-yl)aminoacetyl
Antioxidant Assays
The antioxidant activity was estimated using in vitro tests: ferric reducing power, total antioxidant capacity and radical scavenging ability.
Ferric Reducing Power
The ferric reducing power of the compounds was quantified by the method described by [25] with slight modifications. The sample solution (1 mL, 5 mg/mL in DMSO) was mixed with sodium phosphate buffer (1 mL, 0.2 M, pH 6.6) and potassium ferricyanide (1 mL, 1% w/v) in a test tube. The reaction mixture was incubated at 50 °C for 20 min in a water bath and then the reaction was stopped by adding trichloroacetic acid (1 mL, 10% w/v). After centrifugation of the mixture at 4500 rpm for 15 min, the upper layer of the solution (1mL) was collected and diluted further by adding deionised water (1 mL) and ferric chloride (0.2 mL, 0.1% w/v). After 5 min of incubation, the absorbance was measured at 700 nm against a blank (the mixture of DMSO with the reagents). A higher absorbance indicates a higher reducing power. For each sample it was calculated the effective concentration (EC 50 ) and the reducing power was expressed in reference with ascorbic acid (AA) in the same concentration.
Total Antioxidant Activity
The antioxidant activity of tested compounds was evaluated using the phosphomolybdenum method according to the procedure of [26] with minor modifications. The method is based on the reduction of Mo(VI) to Mo(V) by the tested compounds followed by the formation of a green phosphate/Mo(V) complex at acid pH. An aliquot of sample solution (50 µL, 5 mg/mL in DMSO) is mixed with the reagent solution (2 mL, 0.6 M sulphuric acid, 28 mM sodium phosphate and 4 mM ammonium molybdate). The samples were incubated at 95 °C for 90 min and then were cooled to room temperature. The absorbance was measured at 695 nm against a blank (DMSO mixed with reagent solution). For each sample the effective concentration (EC 50 ) was calculated and the antioxidant activity was expressed in reference with ascorbic acid (AA) in the same concentration.
DPPH Radical Scavenging Assay
The radical scavenging activity of the tested compounds towards the radical 1,1-diphenyl-2-picrylhydrazyl (DPPH) was measured as described by [27] with slight modifications. The sample solution (50 µL, 20 mg/mL in DMSO) was mixed thoroughly with a solution of DPPH in methanol (2.95 mL, 0.1 mM). The sample was left for 30 min at room temperature, in the dark, and after that the absorbance was measured at 517 nm (A s ). A methanol solution of DPPH was used as control sample (A c ). The ability to scavenge the DPPH radical was calculated using the following formula: % Inhibition = 100 × (Ac−As)/Ac and it was expressed in reference with the radical scavenging activity of ascorbic acid (AA) in the same concentration.
Statistical Analysis
All assays (antimicrobial and antioxidant) were carried out in triplicate. Data were analysed by an analysis of variance (ANOVA) (p < 0.05) and were expressed as means ± SD. The total antioxidant antivity (EC 50 values) were calculated by linear interpolation between values above and below 50% activity.
Conclusions
In this study new N-(arylidene)hydrazinoacetyl and new 2-azetidionone derivatives have been designed and synthesized starting from sulfadiazine and sulfizoxazole. The structures of all new compounds were proved using spectral methods. The compounds were evaluated for their antimicrobial and antioxidant activity. Although their antimicrobial potential was reduced, they shown excellent antioxidant properties; for some of them the potential is comparable with the antioxidant activity of ascorbic acid. These results support the antioxidant potential of the synthesized compounds and their applications in several disease mediated by reactive oxygen species (ROS) including the healing of the wounds.
